drugset
drugset / Trial / NCT01430065

Pharmacokinetic Interaction Study to Assess the Effect of ASP015K on Tacrolimus in Healthy Volunteers

NCT01430065 ↗

Phase 1 Completed 24 enrolled Astellas Pharma Inc
Non-randomizedSingle-groupOpen-label

Summary

This study characterizes the pharmacokinetic effects of ASP015K on Tacrolimus in healthy volunteers.

Timeline

Start
2009-06
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule — Oral
Subject peficitinib Small molecule — Oral

Indications

No indication recorded.